Tags

Type your tag names separated by a space and hit enter

[Treatment for pancreatic endocrine tumors with or without multiple endocrine neoplasia type 1].
Nihon Geka Gakkai Zasshi. 2005 Aug; 106(8):472-8.NG

Abstract

Recent strategies for the treatment of pancreatic endocrine tumors are described. Most cases are metastatic, and liver metastasis is the most significant prognostic factor. Thus curative resection before liver metastasis develops based on the localization of the tumors with the SASI test is the standard strategy. Subtotal distal pancreatectomy or pancreas-preserving total duodenectomy is indicated for multiple pancreatic endocrine tumors and multiple duodenal gastrinomas, respectively, for patients with multiple endocrine neoplasia type 1.

Authors+Show Affiliations

Kyoto University, Director Osaka Saiseikai Noe Hospital, Osaka, Japan.

Pub Type(s)

English Abstract
Journal Article
Review

Language

jpn

PubMed ID

16119110

Citation

Imamura, Masayuki. "[Treatment for Pancreatic Endocrine Tumors With or Without Multiple Endocrine Neoplasia Type 1]." Nihon Geka Gakkai Zasshi, vol. 106, no. 8, 2005, pp. 472-8.
Imamura M. [Treatment for pancreatic endocrine tumors with or without multiple endocrine neoplasia type 1]. Nihon Geka Gakkai Zasshi. 2005;106(8):472-8.
Imamura, M. (2005). [Treatment for pancreatic endocrine tumors with or without multiple endocrine neoplasia type 1]. Nihon Geka Gakkai Zasshi, 106(8), 472-8.
Imamura M. [Treatment for Pancreatic Endocrine Tumors With or Without Multiple Endocrine Neoplasia Type 1]. Nihon Geka Gakkai Zasshi. 2005;106(8):472-8. PubMed PMID: 16119110.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Treatment for pancreatic endocrine tumors with or without multiple endocrine neoplasia type 1]. A1 - Imamura,Masayuki, PY - 2005/8/27/pubmed PY - 2005/10/1/medline PY - 2005/8/27/entrez SP - 472 EP - 8 JF - Nihon Geka Gakkai zasshi JO - Nihon Geka Gakkai Zasshi VL - 106 IS - 8 N2 - Recent strategies for the treatment of pancreatic endocrine tumors are described. Most cases are metastatic, and liver metastasis is the most significant prognostic factor. Thus curative resection before liver metastasis develops based on the localization of the tumors with the SASI test is the standard strategy. Subtotal distal pancreatectomy or pancreas-preserving total duodenectomy is indicated for multiple pancreatic endocrine tumors and multiple duodenal gastrinomas, respectively, for patients with multiple endocrine neoplasia type 1. SN - 0301-4894 UR - https://www.unboundmedicine.com/medline/citation/16119110/[Treatment_for_pancreatic_endocrine_tumors_with_or_without_multiple_endocrine_neoplasia_type_1]_ L2 - http://www.diseaseinfosearch.org/result/4954 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.